加拿大Akela Pharma
Akela Pharma Inc. (蒙特娄，Montreal)，一家专精于开发吸入剂及止痛剂的药物开发公司
A world leader in pharmaceutical development
Akela Pharma has emerged as one of the world leaders for inhaled therapeutics.Its pipeline includes inhalation therapies for pain management, growth hormone deficiencies, asthma and abuse deterrent formulations.
Akela Pharma is an integrated drug development company focused on developing therapies for the growing multi-billion dollar inhalation, pain and CNS markets. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, growth hormone deficiencies and controlled substance abuse deterrent formulations.

Akela's common shares trade on The Toronto Stock Exchange ("TSX") under the symbol "AKL" with 82.3 million shares outstanding.